Enzo Biochem Reports Second Quarter Fiscal Year 2023 Financial Results
21 mars 2023 09h43 HE
|
Enzo Biochem, Inc.
- Company entered into an Asset Purchase Agreement for substantially all of the operating assets of the Clinical Labs division - Enzo Life Sciences reports revenue of $7.5 million, with Jan-23...
Enzo Biochem Agrees to Sell Clinical Laboratory to Labcorp
16 mars 2023 16h30 HE
|
Enzo Biochem, Inc.
Significant value unlocked for Enzo shareholders with continued focus on remaining businesses. FARMINGDALE, NY, March 16, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) announced...
Enzo Biochem Reports First Quarter Fiscal Year 2023 Financial Results and Provides Business Update
12 déc. 2022 17h29 HE
|
Enzo Biochem, Inc.
- Enzo Life Sciences reports revenue of $7.1 million and 9% growth in Q1 FY 2023, excluding FX - Engagement with investment bank to provide advisory services including the evaluation of strategic...
Enzo Biochem, Inc. to Report First Quarter Fiscal 2023 Financial Results and Business Update on Monday, December 12th
07 déc. 2022 18h18 HE
|
Enzo Biochem, Inc.
Conference Call and Webcast Scheduled for December 13th, 8:30 AM ET New York, NY, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics...
Enzo Biochem, Inc. Announces Date of Annual Shareholders’ Meeting
08 nov. 2022 18h04 HE
|
Enzo Biochem, Inc.
NEW YORK, NY, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced that its Annual Shareholders’...
Enzo Biochem, Inc. Appoints Patricia Eckert, CPA as Interim CFO
20 oct. 2022 08h15 HE
|
Enzo Biochem, Inc.
NEW YORK, NY, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the appointment of Patricia...
Enzo Biochem Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update
14 oct. 2022 07h30 HE
|
Enzo Biochem, Inc.
- Enzo Life Sciences reports revenue of $32.6 million and 8% growth in FY 2022, net of FX - Company successfully launched AMPIVIEW™ gene expression platform powered by LoopRNA™ ISH...
Enzo Biochem to Report Fourth Quarter 2022 Financial Results and Business Update on Friday, October 14th
10 oct. 2022 11h31 HE
|
Enzo Biochem, Inc.
Conference Call and Webcast Scheduled for October 14, 2022, 8:30 am ET NEW YORK, NY, Oct. 10, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics...
Enzo Biochem, Inc. Opens Expanded Life Sciences Laboratory and Office Facilities in Farmingdale, New York
06 oct. 2022 08h00 HE
|
Enzo Biochem, Inc.
100,000 square foot facility to support company plans for growth in clinical laboratory services, drug development services and product innovations Launch event to feature updates on Enzo plans for...
Enzo Biochem, Inc. Launches AMPIVIEW™ Gene Expression Platform with First Products Targeting Detection of HPV and SARS-CoV-2
26 sept. 2022 08h00 HE
|
Enzo Biochem, Inc.
NEW YORK, NY, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the launch of the AMPIVIEW™...